A Study of Revumenib in Combination With Chemotherapy for Patients Diagnosed With Relapsed or Refractory Leukemia
Children's Oncology Group
Children's Oncology Group
National Cancer Institute (NCI)
National Cancer Institute (NCI)
M.D. Anderson Cancer Center
National Cancer Institute (NCI)
Alliance for Clinical Trials in Oncology
Eastern Cooperative Oncology Group
Dana-Farber Cancer Institute
St. Jude Children's Research Hospital
Washington University School of Medicine
Massachusetts General Hospital
Sanofi
H. Lee Moffitt Cancer Center and Research Institute
Barbara Ann Karmanos Cancer Institute
National Cancer Institute (NCI)
Sun Yat-sen University
University of Nebraska
Oncotherapeutics
OHSU Knight Cancer Institute
Herlev Hospital
US Oncology Research
Sun Yat-sen University
M.D. Anderson Cancer Center
Mesoblast, Ltd.
Incyte Corporation
Sun Pharmaceutical Industries Limited
H. Lee Moffitt Cancer Center and Research Institute
M.D. Anderson Cancer Center
Children's Oncology Group
Roswell Park Cancer Institute
Roswell Park Cancer Institute
Stanford University
Royal Marsden NHS Foundation Trust
University of Arizona
Gruppo Italiano Malattie EMatologiche dell'Adulto
Case Comprehensive Cancer Center
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University
Bristol-Myers Squibb
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Asan Medical Center
Janssen Research & Development, LLC
Stanford University
Janssen Research & Development, LLC
Royal Marsden NHS Foundation Trust
Stanford University
St. Jude Children's Research Hospital
Masonic Cancer Center, University of Minnesota
University of Louisville
Masonic Cancer Center, University of Minnesota
Masonic Cancer Center, University of Minnesota